Nobiletin Attenuates DSS-Induced Intestinal Barrier Damage through the HNF4α-Claudin-7 Signaling Pathway

被引:25
|
作者
Wen, Xiang [1 ]
Zhao, Hui [1 ]
Wang, Liwen [1 ]
Wang, Liang [1 ]
Du, Gang [1 ]
Guan, Wenqiang [1 ]
Liu, Jianfu [1 ]
Cao, Xiaocang [4 ]
Jiang, Xiaohua [5 ]
Tian, Jingrui [5 ]
Wang, Meiyan [1 ]
Ho, Chi-Tang [3 ]
Li, Shiming [2 ,3 ]
机构
[1] Tianjin Univ Commerce, Tianjin Key Lab Food & Biotechnol, State Expt & Training Ctr Food & Drug, Sch Biotechnol & Food Sci, Tianjin 300134, Peoples R China
[2] Huanggang Normal Univ, Hubei Key Lab EFGIR, Huanggang 438000, Hubei, Peoples R China
[3] Rutgers State Univ, Dept Food Sci, New Brunswick, NJ 07102 USA
[4] Tianjin Med Univ, Dept Gastroenterol & Hepatol, Gen Hosp, Tianjin 300020, Peoples R China
[5] North China Univ Sci & Technol, Sch Basic Med, Dept Histlolgy & Embrylolgy, Tangshan 063210, Hebei, Peoples R China
基金
中国国家自然科学基金;
关键词
claudin-7; HNF-4; alpha; intestinal epithelial barrier; nobiletin; tangerine peels; PROTEIN EXPRESSION; EPITHELIAL BARRIER; INFLAMMATION; CLAUDIN-7; POLYMETHOXYFLAVONES; HOMEOSTASIS; MODULATION;
D O I
10.1021/acs.jafc.0c01217
中图分类号
S [农业科学];
学科分类号
09 ;
摘要
The intestinal epithelium barrier functions to protect human bodies from damages such as harmful microorganisms, antigens, and toxins. In this study, we evaluated the protective effect and molecular mechanism of a dominant polymethoxyflavone nobiletin (NOB) from tangerine peels on intestinal epithelial integrity. The results from transepithelial electrical resistance (TEER) suggested that NOB pretreatment counteracts epithelial injury induced by inflammatory cytokines (TEER value in 48 h: vehicle, 135.6 +/- 3.9 Omega/cm(2); TNF-alpha + IL-1 beta, 90.7 +/- 0.5 Omega/cm(2); 10 mu M NOB + TNF-alpha + IL-1 beta, 126.1 +/- 0.8 52/cm(2); 100 mu M NOB + TNF-alpha + IL-1 beta, 125.3 +/- 0.5 Omega/cm(2). P < 0.001). Clinical and pathological test results suggested that administration of NOB effectively alleviates intestinal barrier injury induced by dextran sulfate sodium (DSS) as evidenced by the length of colon villi on day 7 (control, 253.7 +/- 4.8 mu m, DSS 131.6 +/- 4.6 mu m, NOB + DSS, 234.5 +/- 5.1 mu m. P < 0.001). Interestingly, when screening tight junction molecules for intestinal barrier integrity, we observed that independent treatment with NOB sharply increased claudin-7 levels (ratio of claudin-7 over GAPDH: control, 1.0 +/- 0.06; DSS, 0.02 +/- 0.001; NOB + DSS, 0.3 +/- 0.07. P < 0.001), which was previously suppressed upon DSS stimulation. Furthermore, hepatocyte nuclear factor 4a (HNF-4 alpha) transcriptional regulation of claudin-7 contributed to intestinal barrier homeostasis. Therefore, our study suggests potential intestinal protective strategies based on polymethoxyflavones of aged tangerine peels.
引用
收藏
页码:4641 / 4649
页数:9
相关论文
共 50 条
  • [1] HNF4α Regulates Claudin-7 Protein Expression during Intestinal Epithelial Differentiation
    Farkas, Attila E.
    Hilgarth, Roland S.
    Capaldo, Christopher T.
    Gerner-Smidt, Christian
    Powell, Doris R.
    Vertino, Paula M.
    Koval, Michael
    Parkos, Charles A.
    Nusrat, Asma
    AMERICAN JOURNAL OF PATHOLOGY, 2015, 185 (08): : 2206 - 2218
  • [2] Aspergillus cristatus attenuates DSS-induced intestinal barrier damage through reducing the oxidative stress, regulating short-chain fatty acid and inhibiting MAPK signaling pathways
    Wang, Xin
    Zeng, Xuejun
    Zhang, Xiao
    Wei, Jianping
    Zhang, Yuxiang
    Long, Fangyu
    Yue, Tianli
    Yuan, Yahong
    JOURNAL OF THE SCIENCE OF FOOD AND AGRICULTURE, 2023, 103 (04) : 1736 - 1748
  • [3] Claudin-7 inhibits human lung cancer cell migration and invasion through ERK/MAPK signaling pathway
    Lu, Zhe
    Ding, Lei
    Hong, Heng
    Hoggard, John
    Lu, Qun
    Chen, Yan-Hua
    EXPERIMENTAL CELL RESEARCH, 2011, 317 (13) : 1935 - 1946
  • [4] Berberine ameliorates DSS-induced intestinal mucosal barrier dysfunction through microbiota-dependence and Wnt/β-catenin pathway
    Dong, Yalan
    Fan, Heng
    Zhang, Zhe
    Jiang, Feng
    Li, Mingyue
    Zhou, Haifeng
    Guo, Weina
    Zhang, Zili
    Kang, Zhenyu
    Gui, Yang
    Shou, Zhexing
    Li, Junyi
    Zhu, Rui
    Fu, Yu
    Sarapultsev, Alexey
    Wang, Huafang
    Luo, Shanshan
    Zhang, Ge
    Hu, Desheng
    INTERNATIONAL JOURNAL OF BIOLOGICAL SCIENCES, 2022, 18 (04): : 1381 - 1397
  • [5] The effect of transient receptor potential vanilloid 4 on the intestinal epithelial barrier and human colonic cells was affected by tyrosine-phosphorylated claudin-7
    Huang, Yuan-Yuan
    Li, Jing
    Zhang, He-Rui
    Bai, Su-Wen
    Yang, Hui-Yun
    Shen, Bing
    Du, Juan
    Xia, Xian-Ming
    BIOMEDICINE & PHARMACOTHERAPY, 2020, 122
  • [6] Molecular mechanisms of somatostatin-mediated intestinal epithelial barrier function restoration by upregulating claudin-4 in mice with DSS-induced colitis
    Cai, Lin
    Li, Xiao
    Geng, Chong
    Lei, Xuelian
    Wang, Chunhui
    AMERICAN JOURNAL OF PHYSIOLOGY-CELL PHYSIOLOGY, 2018, 315 (04): : C527 - C536
  • [7] Hinesol attenuates DSS-induced ulcerative colitis through the suppression of Src-mediated NF-κB and chemokine signaling pathway
    Li, Yun-xia
    Liu, Jinzhong
    Li, Fang
    CELL BIOCHEMISTRY AND BIOPHYSICS, 2024, 82 (03) : 2747 - 2757
  • [8] Electroacupuncture preserves intestinal barrier integrity through modulating the gut microbiota in DSS-induced chronic colitis
    Wang, Lingli
    An, Jing
    Song, Shuangning
    Mei, Minhui
    Li, Wenhua
    Ding, Fei
    Liu, Shi
    LIFE SCIENCES, 2020, 261
  • [9] Gastrodin Alleviates DSS-Induced Colitis in Mice through Strengthening Intestinal Barrier and Modulating Gut Microbiota
    Li, Jiahui
    Jia, Jinhui
    Teng, Yue
    Xie, Chunyuan
    Li, Chunwei
    Zhu, Beiwei
    Xia, Xiaodong
    FOODS, 2024, 13 (15)
  • [10] Ginsenoside Rc attenuates DSS-induced ulcerative colitis, intestinal inflammatory, and barrier function by activating the farnesoid X receptor
    Tang, Kaijia
    Kong, Danli
    Peng, Yuan
    Guo, Jingyi
    Zhong, Yadi
    Yu, Haibing
    Mai, Zhenhua
    Chen, Yanling
    Chen, Yingjian
    Cui, Tianqi
    Duan, Siwei
    Li, Tianyao
    Liu, Naihua
    Zhang, Dong
    Ding, Yuanlin
    Huang, Jiawen
    FRONTIERS IN PHARMACOLOGY, 2022, 13